Volatile Anesthetic Sedation for Critically Ill Patients

O’Gara, Brian; Boncyk, Christina; Meiser, Andreas; Jerath, Angela; Bellgardt, Martin; Jabaudon, Matthieu; Beitler, Jeremy R.; Hughes, Christopher G.

doi:10.1097/aln.0000000000004994

Anesthesiology

2024

DOI: 10.1097/aln.0000000000004994

|View full text |Cite

Volatile Anesthetic Sedation for Critically Ill Patients

Brian O’Gara,

Christina Boncyk,

Andreas Meiser

et al.

Abstract: Volatile anesthetics have multiple properties that make them useful for sedation in the intensive care unit. The team-based approach to volatile anesthetic sedation leverages these properties to provide a safe and effective alternative to intravenous sedatives.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 71 publications

(83 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

Malignant Hyperthermia

Pinyavat,

Riazi,

Deng

et al. 2024

Critical Care Medicine

View full text Add to dashboard Cite

Objectives: A narrative expert review aiming to summarize the clinical epidemiology and management of critically ill patients with malignant hyperthermia (MH). Data Sources: Medline searches were conducted to identify relevant articles describing the epidemiology, pathophysiology, and management of MH. Guidelines from key MH organizations were also incorporated into this review. Study Selection: Relevant studies regarding MH in both ICU and perioperative settings were reviewed. Data Extraction: Data from relevant studies were summarized and qualitatively assessed. Data Synthesis: MH is a severe reaction triggered by inhalational volatile anesthetics and succinylcholine in genetically susceptible patients. The condition is characterized by an early onset (min to hr) rise in temperature, hypercarbia, and muscular rigidity following exposure to triggering medications with potential complications of coagulopathy, rhabdomyolysis, and acute kidney injury. Acute management necessitates a coordinated multidisciplinary team approach with specific management using dantrolene, active cooling, and hyperventilation. A suspected MH reaction has important implications for future anesthetic exposure for both the patient and their family. All suspected reactions should be followed up at a specialized MH testing center using muscle contracture and genetic testing. Conclusions: Increasing use of inhalational anesthetics in the ICU underscores the need for enhanced education on the diagnosis and management of MH to ensure optimal patient sedation care and safety.

show abstract

Malignant Hyperthermia

Pinyavat,

Riazi,

Deng

et al. 2024

Critical Care Medicine

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Volatile Anesthetic Sedation for Critically Ill Patients

Abstract: Volatile anesthetics have multiple properties that make them useful for sedation in the intensive care unit. The team-based approach to volatile anesthetic sedation leverages these properties to provide a safe and effective alternative to intravenous sedatives.

Cited by 1 publication

References 71 publications

Malignant Hyperthermia

Malignant Hyperthermia

Contact Info

Product

Resources

About